Exelixis, Inc. (Nasdaq: EXEL) today announced that the company has entered into a clinical development collaboration with Merck, known as MSD outside of the United States and Canada, to supply ...

An artificial intelligence model from the Mayo Clinic detected early signs of possible pancreatic cancer on scans up to two years before patients were diagnosed.

A new stem-cell-derived model suggests human pancreatic cells require multiple genetic failures before becoming cancerous and ...

A new daily pill called daraxonrasib is showing promise against advanced pancreatic cancer in a first-in-human trial of 168 ...

New research on more than 100 cancer risk factors suggests that simple life changes can help prevent cancer or spot it early ...

A team of Rice University bioengineers has developed a new way to create highly realistic "mock" patient samples that could ...

BostonGene, a leader in AI-powered solutions for drug discovery and development, is transforming how pharmaceutical companies develop, target, and deliver cancer therapies — making precision medicine ...

One of the greatest challenges with ovarian cancer is that it is difficult to detect in its early stages. Symptoms of ovarian ...